Royal Bank of Canada’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,397
| Closed | -$51K | – | 7784 |
|
|
2022
Q4 | $51K | Buy |
2,397
+1,916
| +398% | +$40.5K | ﹤0.01% | 5872 |
|
|
2022
Q3 | $10K | Buy |
481
+351
| +270% | +$7.26K | ﹤0.01% | 6445 |
|
|
2022
Q2 | $3K | Sell |
130
-906
| -87% | -$23.9K | ﹤0.01% | 6896 |
|
|
2022
Q1 | $31K | Sell |
1,036
-2,714
| -72% | -$79.5K | ﹤0.01% | 6372 |
|
|
2021
Q4 | $87K | Buy |
3,750
+2,305
| +160% | +$61.3K | ﹤0.01% | 6040 |
|
|
2021
Q3 | $45K | Buy |
1,445
+190
| +15% | +$5.88K | ﹤0.01% | 6230 |
|
|
2021
Q2 | $45K | Buy |
1,255
+103
| +9% | +$3.35K | ﹤0.01% | 6116 |
|
|
2021
Q1 | $41K | Buy |
1,152
+90
| +8% | +$3.32K | ﹤0.01% | 6014 |
|
|
2020
Q4 | $40K | Buy |
1,062
+555
| +109% | +$20.2K | ﹤0.01% | 5755 |
|
|
2020
Q3 | $17K | Sell |
507
-122
| -19% | -$3.55K | ﹤0.01% | 5764 |
|
|
2020
Q2 | $17K | Buy |
629
+467
| +288% | +$11K | ﹤0.01% | 5664 |
|
|
2020
Q1 | $3K | Sell |
162
-510
| -76% | -$11.2K | ﹤0.01% | 6236 |
|
|
2019
Q4 | $18K | Buy |
672
+572
| +572% | +$11.4K | ﹤0.01% | 5914 |
|
|
2019
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 6338 |
|
|
2019
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 6516 |
|
|
2019
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 6471 |
|
|
2018
Q4 | $2K | Sell |
100
-173
| -63% | -$4.57K | ﹤0.01% | 6498 |
|
|
2018
Q3 | $9K | Buy |
273
+96
| +54% | +$3.14K | ﹤0.01% | 6048 |
|
|
2018
Q2 | $7K | Buy |
177
+77
| +77% | +$2.49K | ﹤0.01% | 5958 |
|
|
2018
Q1 | $3K | Buy |
100
+90
| +900% | +$3.03K | ﹤0.01% | 6072 |
|
|
2017
Q4 | $0 | Buy |
+10
| New | +$254 | ﹤0.01% | 7030 |
|
Other funds holding ALBO
Royal Bank of Canada's ALBO Position: Q1 2023 in Review
Royal Bank of Canada sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 2,397 shares — an estimated $51K sold.
Royal Bank of Canada first reported a position in ALBO in Q4 2017 and held it in 21 quarters. The position peaked at $87K in Q4 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Royal Bank of Canada reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Royal Bank of Canada sold 2,397 Albireo Pharma Inc shares in Q1 2023, an estimated $51K.
- Royal Bank of Canada first reported a position in Albireo Pharma Inc in Q4 2017 and held it in 21 quarters.
- Royal Bank of Canada's Albireo Pharma Inc position peaked at $87K in Q4 2021.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.